In our latest article, we look at how the dual delivery of siRNA – via delivery systems such as Nuvec® – holds the potential to pave the way for a new era of improved efficiency in cancer treatment. Nuvec® has the potential to offer a solution that reduces the toxicity associated with chemotherapy and improves on the limited efficacy of immunotherapy.

Read the article published in Drug Discovery Today here: